Genmab — September 2019
-
ca. 40.000
-
Næsten 30% af dagens omsætning.
-
Det er vel næsten blevet det nye "normale".
-
Det har du ret i.
-
Så mon ikke den suser forbi 1400 i morgen..;-)
-
Budsiden blev hele dagen igennem fyldt op med købere. De var tålmodig og forsigtige. Det var helt klart, at de ikke ønskede at presse prisen op.
-
Likvider er investeret i obligationer. Kan du se i regnskabets noter
-
In accordance with the group’s risk management guidelines, Genmab’s marketable securities are administrated by two external investment managers who solely invest in securities from investment grade issuers. Genmab invests its cash in deposits with major financial institutions, Danish mortgage bonds and notes issued by Danish, European, and American governments.
-
As of June 30, 2019, 90% of our marketable securities had a triple A-rating, compared to 90% as of December 31, 2018.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind